01. Feb 2016
AVA Biochem expands portfolio to include FDCA
AVA Biochem, world leader in 5-HMF production, is expanding its product portfolio to include platform chemical FDCA (2,5-Furandicarboxylic acid). In addition to 5-HMF, the Swiss company will now deliver high-quality FDCA to customers and partners engaged in research and development of new products.
Furan derivatives produced from renewable carbohydrates are some of the most important next-generation platform chemicals. In 2004, the US Department of Energy classed FDCA as one of the 12 most important platform chemicals in the world.
AVA Biochem’s 5-HMF production is based on hydrothermal processing technology (HPT) and is an excellent, cost-efficient basis for the oxidation of 5-HMF to FDCA. Significant cost advantages can be realised on an industrial scale, paving the way for competitively priced bio-based packaging solutions in the future.
FDCA produced from 5-HMF allows for the production of bio-based PEF (polyethylene furanoate) and other materials. Thanks to a variety of sought after product advantages, these materials will help bio-based plastics to massively grow its share in the billion-dollar packaging market.
“Expanding the product portfolio to include FDCA is another important milestone for AVA Biochem. This will significantly accelerate market development of 100% bio-based plastic packaging based on PEF, a renewable replacement material for PET”, explains Thomas Kläusli, Chief Marketing Officer of the Swiss biochemical company.
AVA Biochem is a subsidiary of AVA-CO2 Schweiz AG, Zug and is located in Muttenz, Switzerland. The world’s first industrial plant for production of ‘Swiss-Made’ 5-HMF from biomass is operated in Muttenz.
http://www.ava-biochem.com